Displaying drugs 2676 - 2700 of 2785 in total
| Name | Weight | Structure | Description | Categories |
|---|---|---|---|---|
| Bisoctrizole | 658.891 C41H50N6O2 |  | An absorber of UVA and UVB radiation used in sunscreen. | Sunscreen Agents |
| Lansoprazole | 369.361 C16H14F3N3O2S |  | A proton pump inhibitor used to help gastrointestinal ulcers heal, to treat symptoms of gastroesophageal reflux disease (GERD), to eradicate Helicobacter pylori, and to treat hypersecretory conditions such as Zollinger-Ellison Syndrome. | Anti-Ulcer Agents / Proton Pump Inhibitors |
| Sarecycline | 487.509 C24H29N3O8 |  | A tetracycline antibiotic used to treat inflammatory lesions of non-nodular moderate to severe acne vulgaris. | Anti-Bacterial Agents / Dermatologicals / Tetracyclines |
| Telotristat ethyl | 574.99 C27H26ClF3N6O3 |  | A tryptophan hydroxylase inhibitor that is used to treat carcinoid syndrome diarrhea. | Tryptophan Hydroxylase Inhibitor |
| Ceritinib | 558.135 C28H36ClN5O3S |  | An antineoplastic kinase inhibitor used to treat anaplastic lymphoma kinase (ALK)-positive metastatic non-small cell lung cancer (NSCLC) in patients with inadequate clinical response or intolerance to crizotinib. | Anaplastic lymphoma kinase (ALK) inhibitors / Protein Kinase Inhibitors |
| Cetalkonium | 360.649 C25H46N |  | An antiseptic used as a preservative or to treat certain topical infections. | Anti-Infective Agents, Local / Surface-Active Agents |
| Copanlisib | 480.529 C23H28N8O4 |  | A PI3K inhibitor used to treat relapsed follicular lymphoma in adults. | Phosphatidylinositol-3-kinase (Pi3K) inhibitors |
| Levamlodipine | 408.88 C20H25ClN2O5 |  | A calcium channel blocker used to treat hypertension. | Dihydropyridine Derivatives |
| Daptomycin | 1620.693 C72H101N17O26 |  | A cyclic lipopeptide antibiotic used to treat complicated skin and skin structure infections by susceptible Gram-positive bacteria and bacteremia due to Staphylococcus aureus. | Anti-Bacterial Agents / Lipopeptide Antibacterial / Lipopeptides / Peptides, Cyclic |
| Suvorexant | 450.93 C23H23ClN6O2 |  | A orexin receptor antagonist used to treat insomnia that is characterized by difficulties with sleep onset and/or sleep maintenance. | Orexin Receptor Antagonists / Sleep Aids, Pharmaceutical |
| Acetaminophen | 151.1626 C8H9NO2 |  | An analgesic drug used alone or in combination with opioids for pain management, and as an antipyretic agent. | Anilides |
| Hydroxyamphetamine | 151.2056 C9H13NO |  | An indirectly acting sympathomimetic agent producing mydriasis for diagnostic purposes. | Adrenergic Agonists / Amphetamines / Mydriatics / Sympathomimetics |
| Phenylacetic acid | 136.1479 C8H8O2 |  | An agent used as an adjunct to treat acute hyperammonemia and associated encephalopathy in adult and pediatric patients with deficiencies in enzymes of the urea cycle. | Various Alimentary Tract and Metabolism Products |
| Monobenzone | 200.2332 C13H12O2 |  | A hydroquinone derivative used to treat vitiligo. | Depigmenting Agents |
| Capmatinib | 412.428 C23H17FN6O |  | A kinase inhibitor targeting c-Met receptor tyrosine kinase in the treatment of non-small cell lung cancer with MET exon 14 skipping. | Kinase Inhibitor |
| Pexidartinib | 417.82 C20H15ClF3N5 |  | An antitumor agent that is used for the treatment of rare disease tenosynovial giant cell tumors (TGCT) by inhibiting colony-stimulating factor 1 and its receptor. | Amines / Antineoplastic Agents / Antineoplastic and Immunomodulating Agents / Cancer immunotherapy / Cytochrome P-450 CYP2B6 Inducers / Cytochrome P-450 CYP2B6 Inducers (strength unknown) / Cytochrome P-450 CYP2B6 Inhibitors / Cytochrome P-450 CYP2B6 Inhibitors (strength unknown) / Cytochrome P-450 CYP2C9 Inhibitors / Cytochrome P-450 CYP2C9 Inhibitors (strength unknown) / Cytochrome P-450 CYP3A Inducers / Cytochrome P-450 CYP3A Inhibitors / Cytochrome P-450 CYP3A Substrates / Cytochrome P-450 CYP3A4 Inducers / Cytochrome P-450 CYP3A4 Inducers (weak) / Cytochrome P-450 CYP3A4 Inhibitors / Cytochrome P-450 CYP3A4 Inhibitors (weak) / Cytochrome P-450 CYP3A4 Substrates / Cytochrome P-450 CYP3A4 Substrates with a Narrow Therapeutic Index / Cytochrome P-450 Enzyme Inducers / Cytochrome P-450 Enzyme Inhibitors / Cytochrome P-450 Substrates / Hepatotoxic Agents / Immunotherapy / Kinase Inhibitor / MATE 1 Inhibitors / MATE 2 Inhibitors / MATE inhibitors / Narrow Therapeutic Index Drugs / OATP1B1/SLCO1B1 Inhibitors / OATP1B3 inhibitors / Organic Anion Transporting Polypeptide 2B1 Inhibitors / Protein Kinase Inhibitors / Pyridines / Tyrosine Kinase Inhibitors / UGT1A1 Inhibitors / UGT1A4 substrates |
| Dotatate gallium Ga-68 | 1500.54 C65H87GaN14O19S2 |  | Dotatate gallium 68 is one of the most prominent radiopharmaceuticals used in imaging with positron emission tomography. It binds to the somatostatin-2 receptor which is usually overexpressed in many neuroendocrine... | Gallium Radioisotopes / Radioactive Diagnostic Agent |
| Levetiracetam | 170.212 C8H14N2O2 |  | A novel anticonvulsant agent used as an adjunct medication to manage partial onset, myoclonic, and generalized tonic-clonic seizures in patients with epilepsy. | Central Nervous System Depressants |
| Pantoprazole | 383.37 C16H15F2N3O4S |  | A proton pump inhibitor used to treat erosive esophagitis, gastric acid hypersecretion, and to promote healing of tissue damage caused by gastric acid. | 2-Pyridinylmethylsulfinylbenzimidazoles / Anti-Ulcer Agents / Proton Pump Inhibitors |
| Maprotiline | 277.4033 C20H23N |  | A tetracyclic antidepressant used to treat depressive illness, major depressive disorder, bipolar disorder, and anxiety associated with depression. | Non-Selective Monoamine Reuptake Inhibitors |
| Lifitegrast | 615.48 C29H24Cl2N2O7S |  | A medication used to treat dry eye disease. | Lymphocyte Function-Associated Antigen-1 / Lymphocyte Function-Associated Antigen-1 Antagonist / Ophthalmic Solutions |
| Valbenazine | 418.578 C24H38N2O4 |  | A vesicular monoamine transporter 2 inhibitor used to treat tardive dyskinesia and chorea associated with Huntington's disease. | Vesicular Monoamine Transporter 2 Inhibitor |
| Huperzine A | 242.3162 C15H18N2O |  | Investigated for use/treatment in alzheimer's disease. | Cholinesterase Inhibitors / Neuroprotective Agents |
| Difelikefalin | 679.863 C36H53N7O6 |  | A kappa opioid receptor agonist used in the treatment of pruritus associated with chronic kidney disease in patients undergoing hemodialysis. | Kappa Opioid Receptor Agonist |
| Glyburide | 494.004 C23H28ClN3O5S |  | A sulfonylurea used in the treatment of non insulin dependent diabetes mellitus. | Sulfonylureas |
Displaying drugs 2676 - 2700 of 2785 in total